DR

Dilip Rajendra Suryawanshi

Active Director Director DIN 09672674
DIN 09672674 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Dilip Rajendra Suryawanshi

Data last updated:

Dilip Rajendra Suryawanshi is a Director at Induscure Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09672674
Primary Designation Director
Industry Chemicals
First Appointment 21 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20222022Active

Directorship timeline

Open interactive timeline →
Induscure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dilip Rajendra Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Rajendra Suryawanshi

Dilip Rajendra Suryawanshi currently holds 1 directorship: Induscure Pharmaceuticals Private Limited (Director, since 21 Jul 2022).

Dilip Rajendra Suryawanshi was first appointed on 21 Jul 2022 as Director at Induscure Pharmaceuticals Private Limited.

The current boards of Dilip Rajendra Suryawanshi's companies include Abhijit Harishchandra Kamble (Induscure Pharmaceuticals Private Limited), Vijay Balasaheb Jagadale (Induscure Pharmaceuticals Private Limited), Vijay Vishnu Joshi (Induscure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available